One Utilizes CRISPR Technology, Offering Hope for Patients Battling the Debilitating Blood Disorder In a historic move, the Food and Drug Administration (FDA) has granted approval for two gene therapies designed to treat sickle cell disease, a painful and hereditary blood disorder predominantly affecting Black individuals in the U.S. These breakthrough treatments, deemed potential cures, … Read more